Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases
A Trpkovic, I Resanovic, J Stanimirovic… - Critical reviews in …, 2015 - Taylor & Francis
Atherosclerosis is a life-long illness that begins with risk factors, which in turn contribute to
the development of subclinical disease, followed by the establishment of overt …
the development of subclinical disease, followed by the establishment of overt …
Arterial hypertension—Oxidative stress and inflammation
J Krzemińska, M Wronka, E Młynarska, B Franczyk… - Antioxidants, 2022 - mdpi.com
Arterial hypertension (AH) is a major cause of cardiovascular diseases (CVD), leading to
dysfunction of many organs, including the heart, blood vessels and kidneys. AH is a …
dysfunction of many organs, including the heart, blood vessels and kidneys. AH is a …
Reactive oxygen species, vascular Noxs, and hypertension: focus on translational and clinical research
AC Montezano, RM Touyz - Antioxidants & redox signaling, 2014 - liebertpub.com
Significance: Reactive oxygen species (ROS) are signaling molecules that are important in
physiological processes, including host defense, aging, and cellular homeostasis. Increased …
physiological processes, including host defense, aging, and cellular homeostasis. Increased …
A review of nebivolol pharmacology and clinical evidence
J Fongemie, E Felix-Getzik - Drugs, 2015 - Springer
Nebivolol is a highly selective β 1-adrenergic receptor antagonist with a pharmacologic
profile that differs from those of other drugs in its class. In addition to cardioselectivity …
profile that differs from those of other drugs in its class. In addition to cardioselectivity …
Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease
T Chalermpalanupap, B Kinkead, WT Hu… - Alzheimer's research & …, 2013 - Springer
The Alzheimer's disease (AD) epidemic is a looming crisis, with an urgent need for new
therapies to delay or prevent symptom onset and progression. There is growing awareness …
therapies to delay or prevent symptom onset and progression. There is growing awareness …
Hypertension, antihypertensive medication use, and risk of psoriasis
S Wu, J Han, WQ Li, AA Qureshi - JAMA dermatology, 2014 - jamanetwork.com
Importance Individuals with psoriasis have an elevated risk of hypertension, and
antihypertensive medications, especially β-blockers, have been linked to psoriasis …
antihypertensive medications, especially β-blockers, have been linked to psoriasis …
Comparative effects of nebivolol and metoprolol on red cell distribution width and neutrophil/lymphocyte ratio in patients with newly diagnosed essential hypertension
High level of circulating red cell distribution width (RDW) and neutrophil/lymphocyte (N/L)
ratio may reflect ongoing vascular inflammation and play an important role in …
ratio may reflect ongoing vascular inflammation and play an important role in …
[HTML][HTML] Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension
Nebivolol and metoprolol are β 1-adrenergic receptor blockers with different properties. We
hypothesized that nebivolol, but not metoprolol, could attenuate prooxidant and profibrotic …
hypothesized that nebivolol, but not metoprolol, could attenuate prooxidant and profibrotic …
Inflammation markers in essential hypertension
D Tsounis, G Bouras, G Giannopoulos… - Medicinal …, 2014 - ingentaconnect.com
Essential hypertension is a common health disorder with uncertain etiology and unclear
pathophysiology. There is evidence that various systems interact in uncertain ways and …
pathophysiology. There is evidence that various systems interact in uncertain ways and …
Association of asthma–chronic obstructive pulmonary disease overlap syndrome with coronary artery disease, cardiac dysrhythmia and heart failure: a population …
Objectives Patients with asthma–chronic obstructive pulmonary disease (COPD) overlap
syndrome (ACOS) and cardiovascular diseases (CVDs) share common risk factors …
syndrome (ACOS) and cardiovascular diseases (CVDs) share common risk factors …